Targeted proteomic analysis of 14-3-3σ in nasopharyngeal carcinoma

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 1, 2010, Pages 137-147

  Huang, Wei Guo ^a,b   Cheng, Ai Lan ^a,b   Chen, Zhu Chu ^a   Peng, Fang ^a   Zhang, Peng Fei ^a   Li, Mao Yu ^a   Li, Feng ^a   Li, Jian Ling ^a   Li, Cui ^a   Yi, Hong ^a   Li, Xin Hui ^a   Yi, Bin ^a   Xiao, Zhi Qiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

14 3 3 ; Cellular biology; Nasopharyngeal carcinoma; Protein protein interaction; Targeted proteomics

Indexed keywords

CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR; STRATIFIN;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CARCINOMA CELL; CELL INVASION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; METASTASIS; NASOPHARYNX CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; EXONUCLEASES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KERATIN-8; MASS SPECTROMETRY; MULTIPROTEIN COMPLEXES; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEOMICS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 70549096069     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.10.001     Document Type: Article

References (48)

1. Agulnik M., and Siu L.L. State-of-the-art management of nasopharyngeal carcinoma: current and future directions. Br J Cancer 92 (2005) 799-806
2. Ang K.K., Berkey B.A., Tu X., Zhang H.Z., Katz R., Hammond E.H., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 (2002) 7350-7356
3. Benzinger A., Muster N., Koch H.B., Yates III J.R., and Hermeking H. Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 4 (2005) 785-795
4. Berger M.S., Greenfield C., Gullick W.J., Haley J., Downward J., Neal D.E., et al. Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 56 (1987) 533-537
5. Bock J.B., Matern H.T., Peden A.A., and Scheller R.H. A genomic perspective on membrane compartment organization. Nature 409 (2001) 839-841
6. Bossuyt V., Fadare O., Martel M., Ocal I.T., Burtness B., Moinfar F., et al. Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation. Int J Surg Pathol 13 (2005) 319-327
7. Ceresa B.P. Regulation of EGFR endocytic trafficking by rab proteins. Histol Histopathol 21 (2006) 987-993
8. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., and Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401 (1999) 616-620
9. Cheng A.L., Huang W.G., Chen Z.C., Peng F., Zhang P.F., Li M.Y., et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res 14 (2008) 435-445
10. Cheng A.L., Huang W.G., Chen Z.C., Zhang P.F., Li M.Y., Li F., et al. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res 7 (2008) 2415-2426
11. Coulombe P.A., and Omary M.B. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14 (2002) 110-122
12. Fong Y., Chou S.J., Hung K.F., Wu H.T., and Kao S.Y. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. J Chin Med Assoc 71 (2008) 123-127
13. Gullick W.J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47 (1991) 87-98
14. Hammer III J.A., and Wu X.S. Rabs grab motors: defining the connections between Rab GTPases and motor proteins. Curr Opin Cell Biol 14 (2002) 69-75
15. Han B., Xie H., Chen Q., and Zhang J.T. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma. Mol Cancer Ther 5 (2006) 903-912
16. Hara A., and Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 108 (2004) 43-48
17. Hembrough T.A., Vasudevan J., Allietta M.M., Glass II W.F., and Gonias S.L. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci 108 (1995) 1071-1082
18. Hendrix M.J., Seftor E.A., Chu Y.W., Trevor K.T., and Seftor R.E. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 15 (1996) 507-525
19. Herrmann H., and Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 12 (2000) 79-90
20. Hirsch F.R., Varella-Garcia M., Cappuzzo F., McCoy J., Bemis L., Xavier A.C., et al. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann Oncol 18 (2007) 752-760
21. Ho H.C., Lee M.S., Hsiao S.H., Hwang J.H., Hung S.K., Lee C.C., et al. Prognostic influence of parapharyngeal extension in nasopharyngeal carcinoma. Acta Otolaryngol 128 (2008) 790-798
22. Hu Z., Mellor J., Wu J., Yamada T., Holloway D., and Delisi C. VisANT: data-integrating visual framework for biological networks and modules. Nucleic Acids Res 33 Web Server issue (2005) W352-W357
23. Hu Z., Ng D.M., Yamada T., Chen C., Kawashima S., Mellor J., et al. VisANT 3.0: new modules for pathway visualization, editing, prediction and construction. Nucleic Acids Res 35 (2007) W625-W632
24. Kim M.A., Lee H.S., Lee H.E., Jeon Y.K., Yang H.K., and Kim W.H. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 52 (2008) 738-746
25. Laronga C., Yang H.Y., Neal C., and Lee M.H. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275 (2000) 23106-23112
26. Lee M.H., and Lozano G. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol 16 (2006) 225-234
27. Lodygin D., and Hermeking H. Epigenetic silencing of 14-3-3sigma in cancer. Semin Cancer Biol 16 (2006) 214-224
28. Mhawech P. 14-3-3 proteins-an update. Cell Res 15 (2005) 228-236
29. Mogilner A., and Oster G. Cell motility driven by actin polymerization. Biophys J 71 (1996) 3030-3045
30. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
31. Novick P., and Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 9 (1997) 496-504
32. Nuoffer C., and Balch W.E. GTPases: multifunctional molecular switches regulating vesicular traffic. Annu Rev Biochem 63 (1994) 949-990
33. O-Charoenrat P., Rhys-Evans P., Modjtahedi H., Court W., Box G., and Eccles S. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 86 (2000) 307-317
34. Palmieri D., Bouadis A., Ronchetti R., Merino M.J., and Steeg P.S. Rab11a differentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells. Breast Cancer Res Treat 100 (2006) 127-137
35. Prasad G.L., Valverius E.M., McDuffie E., and Cooper H.L. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ 3 (1992) 507-513
36. Rodriguez L.G., and Guan J.L. 14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove. J Cell Physiol 202 (2005) 285-294
37. Schaafsma H.E., Ramaekers F.C., van Muijen G.N., Robben H., Lane E.B., Leigh I.M., et al. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases. Am J Pathol 139 (1991) 1389-1400
38. Schaafsma H.E., Van Der Velden L.A., Manni J.J., Peters H., Link M., Rutter D.J., et al. Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J Pathol 170 (1993) 77-86
39. Seabra M.C., and Coudrier E. Rab GTPases and myosin motors in organelle motility. Traffic 5 (2004) 393-399
40. Selvaggi G., Novello S., Torri V., Leonardo E., De Giuli P., Borasio P., et al. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol 15 (2004) 28-32
41. Simons K., and Zerial M. Rab proteins and the road maps for intracellular transport. Neuron 11 5 (1993) 789-799
42. Song L.B., Yan J., Jian S.W., Zhang L., Li M.Z., Li D., et al. Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines. Ai Zheng 21 (2002) 158-162
43. Stossel T.P. The machinery of cell crawling. Sci Am 271 54-55 (1994) 58-63
44. van Hemert M.J., Steensma H.Y., and van Heusden G.P. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23 (2001) 936-946
45. Vokes E.E., Liebowitz D.N., and Weichselbaum R.R. Nasopharyngeal carcinoma. Lancet 350 (1997) 1087-1091
46. Wang J.S., Wang F.B., Zhang Q.G., Shen Z.Z., and Shao Z.M. Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol Cancer Res 6 (2008) 372-382
47. Wilker E.W., van Vugt M.A., Artim S.A., Huang P.H., Petersen C.P., Reinhardt H.C., et al. 14-3-3 sigma controls mitotic translation to facilitate cytokinesis. Nature 446 (2007) 329-332
48. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12 (2002) 421-429